This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on ISI (7)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Liver/ Biliary Tract/ Pancreatic Diseases  • Oncology, Other  • Hepatobiliary Surgery  • Alert me on articles by topic

Ryo Shimada, MD; Hiroshi Imamura, MD; Ataru Nakayama, MD; Shinichi Miyagawa, MD; Seiji Kawasaki, MD

Arch Surg. 2002;137:1384-1388.

Hypothesis  Abrupt occlusion of hemihepatic portal vein induced by preoperative portal vein embolization (PVE) may result in drastic alterations in blood flow and functional mass of the liver.

Design  Prospective study investigating the outcome of an intervention (PVE).

Setting  University tertiary-care referral center.

Patients  Thirteen patients who underwent PVE before extended right hepatectomy.

Main Outcome Measures  The functional plasma flow and functional mass of the liver as well as the volumes of the left and right lobes were assessed before and after PVE. The functional plasma flow and functional mass of the liver were estimated by measuring the hepatic clearances of sorbitol (a high-extraction drug) and antipyrine (a low-extraction drug), respectively. The liver lobar volumes were measured by computed tomography.

Results  Hepatic plasma clearance of sorbitol (mean ± SD; before PVE, 632.9 ± 142.9 mL/min; day 14, 620.2 ± 138.3 mL/min; not significant by 1-way repeated analysis of variance) and that of antipyrine (before PVE, 27.3 ± 12.0 mL/min; day 14, 27.9 ± 13.6 mL/min; P = .85, by paired t test) were stable after PVE. Fourteen days after PVE, the non–PVE-treated lobe was enlarged (mean ± SD, 137% ± 30%) and the PVE-treated lobe was atrophic (mean ± SD, 87% ± 15%); however, the total liver volume did not change significantly.

Conclusions  The functional mass and plasma flow of the entire liver were stable after PVE despite the drastic change in the lobar distribution of the portal blood flow, whereas the non–PVE-treated lobe increased significantly in size. Our findings suggest that PVE leads to an increase in both the volume and the functional capacity of the non–PVE-treated lobe.

From the First Department of Surgery, Shinshu University School of Medicine, Matsumoto, Japan. Dr Imamura is now with the Division of Hepato-Biliary-Pancreatic Surgery, Department of Surgery, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.